Home /
Insights /
Will Life Sciences Companies Face More Scrutiny in 2018?

Will Life Sciences Companies Face More Scrutiny in 2018?

January 9, 2018

Law360

Partners John Bentivoglio and Jennifer Bragg look at key enforcement trends for life sciences companies from 2017 and discuss what to expect in the year ahead.

Stay Connected

@SkaddenArps

April 3 Partner David Schwartz and counsel Risa Salins highlight important considerations for employers impacted by the COV… twitter.com/i/web/status/1…
April 3 Considerations for Commercial Mortgage REITs in a Market Driven by COVID-19 skadden.com/insights/publi…
April 3 Germany Introduces ‘Virtual’ General Meetings for Public Companies skadden.com/insights/publi…